Merck (MRK) Total Debt Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
12.60% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
5.23% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-5.51% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
40.96% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-0.10% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
-11.13% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
3.78% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-10.56% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
8.30% |
| Date | Value |
|---|
| Mar 31, 2026 |
40.96% |
| Dec 31, 2025 |
32.95% |
| Sep 30, 2025 |
8.50% |
| Jun 30, 2025 |
-6.31% |
| Mar 31, 2025 |
1.83% |
| Dec 31, 2024 |
5.87% |
| Sep 30, 2024 |
9.39% |
| Jun 30, 2024 |
2.38% |
| Mar 31, 2024 |
11.30% |
| Dec 31, 2023 |
14.22% |
| Sep 30, 2023 |
14.60% |
| Jun 30, 2023 |
16.57% |
| Mar 31, 2023 |
-3.30% |
| Dec 31, 2022 |
-7.28% |
| Sep 30, 2022 |
15.04% |
| Jun 30, 2022 |
19.39% |
| Mar 31, 2022 |
1.73% |
| Dec 31, 2021 |
4.12% |
| Sep 30, 2021 |
-8.00% |
| Jun 30, 2021 |
-14.10% |
| Mar 31, 2021 |
11.63% |
| Dec 31, 2020 |
20.67% |
| Sep 30, 2020 |
10.17% |
| Jun 30, 2020 |
16.12% |
| Mar 31, 2020 |
8.12% |
| Dec 31, 2019 |
4.91% |
| Sep 30, 2019 |
10.58% |
| Jun 30, 2019 |
13.92% |
| Mar 31, 2019 |
9.93% |
| Dec 31, 2018 |
2.88% |
| Sep 30, 2018 |
-12.61% |
| Jun 30, 2018 |
-6.22% |
| Mar 31, 2018 |
-17.27% |
| Dec 31, 2017 |
-1.74% |
| Sep 30, 2017 |
7.37% |
| Jun 30, 2017 |
2.47% |
| Mar 31, 2017 |
10.50% |
| Dec 31, 2016 |
-5.94% |
| Sep 30, 2016 |
-5.71% |
| Jun 30, 2016 |
-8.53% |
| Mar 31, 2016 |
-14.77% |
| Dec 31, 2015 |
23.40% |
| Sep 30, 2015 |
-4.22% |
| Jun 30, 2015 |
15.11% |
| Mar 31, 2015 |
7.41% |
| Dec 31, 2014 |
-14.59% |
| Sep 30, 2014 |
4.57% |
| Jun 30, 2014 |
-17.93% |
| Dec 31, 2013 |
21.83% |
| Jun 30, 2013 |
48.10% |
| Dec 31, 2012 |
17.44% |
| Jun 30, 2012 |
3.68% |
| Mar 31, 2012 |
1.75% |
| Dec 31, 2011 |
-2.05% |
| Sep 30, 2011 |
0.00% |
| Jun 30, 2011 |
1.80% |
| Mar 31, 2011 |
-6.58% |
| Dec 31, 2010 |
2.33% |
| Sep 30, 2010 |
120.83% |
| Jun 30, 2010 |
120.13% |
